Brian Neel
First SEC filing: Nov. 23, 2020 · Latest: Nov. 23, 2020
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 15, 2023 | MRVI | F | 2,312 | $15.23 | $35,212 | 16,473 Direct | -12.31% | Disposed | -48.1% (price as of 2026-10-02) |
| Oct. 31, 2022 | MRVI | A | 329 | $14.11 | $4,642 | 18,785 Direct | +1.78% | Acquired | -44.0% (price as of 2026-10-02) |
| April 29, 2022 | MRVI | A | 572 | $22.95 | $13,127 | 18,456 Direct | +3.20% | Acquired | -65.6% (price as of 2026-10-02) |
| April 29, 2022 | MRVI | A | 572 | $22.95 | $13,127 | 18,456 Direct | +3.20% | Acquired | -65.6% (price as of 2026-10-02) |
| Jan. 25, 2022 | MRVI | A | 31,500 | · | · | 31,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 25, 2022 | MRVI | A | 17,000 | · | · | 17,884 Direct | +1923.08% | Acquired | (price as of 2026-10-02) |
| Oct. 31, 2021 | MRVI | A | 598 | $22.95 | $13,724 | 884 Direct | +209.09% | Acquired | -65.6% (price as of 2026-10-02) |
| April 30, 2021 | MRVI | A | 286 | $22.95 | $6,564 | 286 Direct | · | Acquired | -65.6% (price as of 2026-10-02) |
| Nov. 19, 2020 | MRVI | A | 60,000 | · | · | 60,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 25, 2022 | MRVI | Employee Stock Option (Right to Buy) | Class A Common Stock | $26.32 | Jan. 25, 2032 | 31,500 | Acquired |
| Nov. 19, 2020 | MRVI | Employee Stock Options (Right to Buy) | Class A Common Stock | $27.00 | Nov. 19, 2030 | 60,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $328,609 | · | · | · | $649,943 | · | $8,550 | $1,861,262 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.